Ligand Pharmaceuticals (LGND) Insider: Stock Move Analysis
A Ligand Pharmaceuticals insider recently sold 5,000 shares, triggering discussions about what insider moves signal f...
Learn effective ways to automate your financial goals, making saving and investing easier. Simplify your path to financial success.
19,013 articlesA Ligand Pharmaceuticals insider recently sold 5,000 shares, triggering discussions about what insider moves signal f...
Two very different apparel plays: FIGS targets a niche medical market with growth potential, while Gildan Activewear ...
Microsoft's latest quarterly dividend yields a nine-figure payment to Steve Ballmer, illustrating the power of long-t...
From Disney screens to a space-focused boardroom, the ex-disney star bridgit mendler now leads Northwood after a $100...
Iran demonstrated it could close the Strait of Hormuz, prompting market volatility. The U.S. counters with new shippi...
When a mining stock pops today, investors sit up. Discover the drivers behind SSR Mining's rally, what it means for r...
Matter Labs is restructuring its workforce as it doubles down on Prividium, a permissioned privacy chain for financia...
When a Opendoor director sells a sizable stake, investors wonder if it hints at trouble or simply liquidity needs. Th...
A Wall Street Journal probe alleges polymarket used staged bets to fuel viral growth, prompting questions about trans...
A single insider sale can spark questions, but it rarely tells the full story. In alignment healthcare stock watch:, ...
A TD Cowen analyst floated SpaceX purchasing T-Mobile, turning heads in investing circles as markets weigh strategic ...
Federal data show a sharp decline in ACA enrollment as subsidies expired, with about 3 million fewer people insured i...